Antimicrobial Agents Practice Questions

Q: A 31-year-old man presents with dysuria and urethral discharge. Gram stain shows intracellular gram-negative diplococci. Local resistance patterns show 28% quinolone resistance. Which of the following most appropriately guides empiric therapy selection?

Local antimicrobial susceptibility patterns. ***Local antimicrobial susceptibility patterns*** - Understanding local resistance patterns is crucial for selecting effective empiric therapy, especially with the high quinolone resistance (28%) mentioned. - **Empiric therapy** for suspected **gonorrhea** (suggested by intracellular gram-negative diplococci) must target common resistance mechanisms to ensure initial treatment success. *Patient preference* - While patient preferences can influence adherence, they do not guide the initial choice of antibiotic for a serious infection like gonorrhea, which requires an effective agent. - Clinical efficacy and public health considerations for preventing resistance take precedence over patient preference in selecting empiric therapy. *Duration of therapy* - The duration of therapy is determined *after* an effective antibiotic is chosen and is based on the specific infection and organism; it does not guide the initial selection of the drug itself. - Most gonorrhea treatments are single-dose, but this is a consequence of the chosen drug's efficacy rather than a guiding principle for selection. *Route of administration* - While practical for the patient, the route of administration (e.g., oral vs. intramuscular) is a secondary consideration after an effective agent is identified based on susceptibility. - Many empiric gonorrhea treatments include an intramuscular injection for single-dose efficacy, making route less of a primary guide for selection. *Organism identification confirmation* - Waiting for definitive organism identification and susceptibility testing would delay treatment and is inappropriate for symptomatic gonorrhea, which requires immediate empiric therapy. - The Gram stain already provides strong presumptive evidence, and empiric treatment must be initiated based on likely pathogens and local resistance patterns rather than waiting for culture confirmation.

Q: A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

Adequate initial hydration. Adequate initial hydration - Intravenous (IV) acyclovir is associated with **nephrotoxicity** due to the formation of **insoluble acyclovir crystals** in the renal tubules, especially in states of dehydration. - **Maintaining adequate hydration** helps in diluting the drug and preventing crystal precipitation, thereby protecting renal function. [1] *Initial administration of allopurinol* - **Allopurinol** is used to prevent **uric acid nephropathy**, typically seen in **tumor lysis syndrome**, not acyclovir-induced crystal nephropathy. [2] - Its administration would not have prevented the formation of **acyclovir crystals**. *Initial administration of glucocorticoids* - **Glucocorticoids** are potent anti-inflammatory agents but do not prevent **drug-induced crystal formation** or directly protect against acyclovir nephrotoxicity. - They are primarily used for inflammatory conditions or to suppress immune responses. *Monitoring of drug levels* - While drug level monitoring can be useful for certain medications to prevent toxicity, it's not the primary preventative measure for **acyclovir-induced crystal nephropathy**. - **Hydration** is more immediate and effective in preventing crystal precipitation. *Obtaining a thorough history of patient allergies* - An allergy history is crucial for preventing **hypersensitivity reactions** to medications, but it would not prevent **nephrotoxicity** due to crystal formation, which is a pharmacokinetic phenomenon. - The patient's renal deterioration is due to **acyclovir crystal nephropathy**, not an allergic reaction.

Q: A 30-year-old man presents to his primary care physician for pain in his left ankle. The patient states that he was at karate practice when he suddenly felt severe pain in his ankle forcing him to stop. The patient has a past medical history notable for type I diabetes and is currently being treated for an episode of acute bacterial sinusitis with moxifloxacin. The patient recently had to have his insulin dose increased secondary to poorly controlled blood glucose levels. Otherwise, the patient takes ibuprofen for headaches and loratadine for seasonal allergies. Physical exam reveals a young healthy man in no acute distress. Pain is elicited over the Achilles tendon with dorsiflexion of the left foot. Pain is also elicited with plantar flexion of the left foot against resistance. Which of the following is the best next step in management?

Change antibiotics and refrain from athletic activities. The patient is experiencing **Achilles tendonitis**, likely a side effect of **moxifloxacin**, which is known to cause **tendinopathy** and **tendon rupture**, especially in patients with **diabetes** or those initiating **corticosteroids** [1]. **Discontinuation of moxifloxacin** and avoidance of strenuous activities are crucial to prevent further tendon damage, with alternative antibiotics for sinusitis [1]. *Refrain from athletic activities for 1 to 2 weeks* - While **refraining from activity** is important, it is insufficient on its own because the underlying cause (moxifloxacin) would persist, potentially worsening the tendon injury. - This option does not address the need to **change the causative medication**, which is the primary intervention for fluoroquinolone-induced tendinopathy [1]. *Rehabilitation exercises and activity as tolerated* - **Rehabilitation exercises** are typically introduced in later stages of recovery, after the acute inflammation has subsided and the causative agent is removed. - **Activity as tolerated** is inappropriate when there is a high risk of **tendon rupture** due to drug-induced tendinopathy; initial management requires strict rest. *Ibuprofen and rest* - **Ibuprofen** can help with pain and inflammation, but it does not address the underlying **fluoroquinolone-induced tendinopathy**. - While **rest** is important, the continued use of moxifloxacin would still predispose the patient to further tendon injury or rupture, making simply resting an incomplete solution.

Q: Drug of choice for nasal carriers of MRSA is:

Mupirocin. ***Mupirocin*** - **Mupirocin** (Bactroban) is a **topical antibacterial agent** frequently used for the eradication of **nasal colonization with MRSA**. - It is applied directly to the **nares** and works by inhibiting bacterial protein synthesis. *Linezolid* - **Linezolid** is an **oral** or **intravenous antibiotic** used for systemic MRSA infections, not typically for nasal decolonization. - Its use for nasal carriage would be inappropriate due to the risk of systemic side effects and potential for resistance development. *Vancomycin* - **Vancomycin** is a **glycopeptide antibiotic** administered intravenously for severe MRSA infections, not for nasal decolonization. - It has poor oral bioavailability and is not effective as a topical agent for nasal carriage. *Teicoplanin* - **Teicoplanin** is another **glycopeptide antibiotic** similar to vancomycin, used for systemic MRSA infections. - Like vancomycin, it is not used for the topical eradication of nasal MRSA colonization.

Q: Praziquantel is used for the treatment of

Schistosomiasis. ***Schistosomiasis*** - **Praziquantel** is the primary drug for treating all species of **schistosomiasis**, effectively killing adult worms [1], [2]. - It works by increasing the **calcium permeability** of the worm's cells, leading to muscle contraction and paralysis [2]. *Rhinosporidiosis* - **Rhinosporidiosis** is a fungal infection, and its treatment typically involves **surgical excision** of the lesions. - Antifungal agents like **dapsone** may be used as an adjuvant therapy, but praziquantel is not indicated. *Strongyloidiasis* - **Strongyloidiasis** is caused by the nematode *Strongyloides stercoralis*, and the preferred treatment is **ivermectin** [3]. - **Albendazole** is an alternative treatment option, but praziquantel is ineffective against this parasite [2], [3]. *Trichomoniasis* - **Trichomoniasis** is a sexually transmitted infection caused by the protozoan *Trichomonas vaginalis*. - It is effectively treated with **metronidazole** or **tinidazole**, while praziquantel has no activity against this protozoan.

Q: Prophylactic dose of Oseltamivir for infants (3-11 months) is?

3 mg/kg/day. ***3 mg/kg/day*** - The recommended **prophylactic dose of oseltamivir** for infants aged 3 to 11 months is **3 mg/kg once daily** for 10 days. - This dosage is essential for preventing **influenza** in this vulnerable age group when exposure is known or highly suspected. *5 mg/kg/day* - A dose of **5 mg/kg** is generally used for **treatment** of influenza in infants and children, not for prophylaxis. - This higher dose is administered twice daily for 5 days when a child is already symptomatic. *1 mg/kg/day* - This dosage is **too low** for either prophylactic or treatment use in infants and would likely be ineffective against influenza. - Sub-optimal dosing can lead to **treatment failure** and a higher risk of complications. *7 mg/kg/day* - This dosage is **higher than recommended** for prophylaxis and could potentially lead to increased adverse effects without offering additional benefit. - Higher doses are usually reserved for **severely immunocompromised** patients or specific treatment regimens, not standard prophylaxis.

Q: Which of the following is the chemoprophylaxis of choice in a person who is on a journey to endemic malarial region?

Atovaquone-proguanil. ***Atovaquone-proguanil*** - **First-line choice** for malaria chemoprophylaxis in travelers to endemic regions according to WHO and CDC guidelines - Highly effective against **drug-resistant *P. falciparum***, including chloroquine and mefloquine-resistant strains - **Excellent tolerability** with minimal side effects compared to other antimalarials - **Convenient dosing schedule**: started 1-2 days before travel and continued for only **7 days after** leaving the endemic area (shorter post-travel duration than alternatives) - Well-tolerated with few contraindications, making it suitable for most travelers *Doxycycline* - Effective alternative for malaria prophylaxis as a **tetracycline antibiotic** - Provides additional protection against **leptospirosis** and traveler's diarrhea - However, associated with **photosensitivity reactions** (sunburn risk), **GI upset**, and **esophageal irritation** - Contraindicated in **pregnancy** and **children <8 years** due to effects on teeth and bone - Requires daily dosing starting 1-2 days before until **4 weeks after travel** (longer duration) *Mefloquine* - Once-weekly dosing offers convenience for long-term travelers - Effective against most *P. falciparum* strains - Major limitation: significant **neuropsychiatric side effects** including anxiety, depression, dizziness, and rarely psychosis - Contraindicated in those with **psychiatric history**, seizure disorders, or cardiac conduction abnormalities - Must be started **2-3 weeks before travel** to assess tolerance *Chloroquine* - Historically the first-line agent but now limited by widespread **chloroquine resistance** - Only effective in few remaining areas with **chloroquine-sensitive *P. vivax*** or *P. falciparum* (parts of Central America, Middle East) - Well-tolerated with once-weekly dosing - Not appropriate for most endemic malarial regions in Africa, Southeast Asia, or South America

Q: Which of the following aminoglycosides is most cochleotoxic:-

Gentamycin. ***Gentamycin*** - **Gentamycin** is known to be the most **cochleotoxic** aminoglycoside, causing irreversible damage to the hair cells in the cochlea [1]. - This toxicity can lead to **permanent hearing loss** and **tinnitus** due to its selective accumulation in inner ear fluids [2]. *Streptomycin* - While streptomycin can cause ototoxicity, its primary adverse effect is vestibulo-toxicity, affecting **balance** more than hearing [2]. - It mainly targets the hair cells of the semicircular canals and otolithic organs, leading to **vertigo** and ataxia [3]. *Amikacin* - Amikacin is also an ototoxic aminoglycoside but is generally considered **less cochleotoxic** than gentamycin. - Its ototoxic effects are comparable to gentamicin, but it is often reserved for infections resistant to other aminoglycosides. *Minocycline* - Minocycline is a **tetracycline antibiotic**, not an aminoglycoside, and is not associated with significant ototoxicity. - Its side effects typically include photosensitivity, gastrointestinal upset, and **vestibular dysfunction** (dizziness, vertigo) in some patients, distinct from cochlear damage.

Q: Empirical drug of choice for treatment of meningococcal meningitis is:-

Ceftriaxone. ***Ceftriaxone*** - As a **third-generation cephalosporin**, **Ceftriaxone** provides excellent coverage against common bacterial causes of meningitis, including *Neisseria meningitidis*. - It achieves high concentrations in the **cerebrospinal fluid (CSF)**, making it highly effective for CNS infections. *Cefotetan* - **Cefotetan** is a **second-generation cephalosporin** that has limited CSF penetration and less reliable coverage against common meningitis pathogens. - While it has activity against some gram-negative bacteria, it is not considered a first-line agent for empirical treatment of meningitis. *Cefoxitin* - **Cefoxitin** is also a **second-generation cephalosporin** with limited ability to cross the blood-brain barrier, making it unsuitable for treating meningitis. - Its spectrum of activity is more focused on anaerobic bacteria and some gram-negative organisms, not typically the main culprits in meningitis. *Gentamicin* - **Gentamicin** is an **aminoglycoside antibiotic** that has poor penetration into the CSF and is less effective as a monotherapy for meningitis. - It is often used in combination with other antibiotics, but not as an empirical monotherapy for suspected meningococcal meningitis.

Q: American Heart Association standard pediatric dose of amoxicillin for antibiotic prophylaxis, in cases of endocarditis is

50mg/kg. ***50mg/kg*** - The **American Heart Association (AHA)** guidelines recommend **50 mg/kg** of amoxicillin as the standard pediatric dose for antibiotic prophylaxis against infective endocarditis before certain dental procedures. - This dose is typically given orally, as a single dose, 30-60 minutes before the procedure. *20mg/kg* - This dose is lower than the recommended **AHA guideline** for infective endocarditis prophylaxis in children. - Administering this dose could result in **subtherapeutic levels**, failing to adequately prevent bacterial colonization and infection. *125mg/kg* - This dosage is significantly higher than the standard **AHA recommendation** for endocarditis prophylaxis. - Such a high dose could increase the risk of **adverse effects** without providing additional prophylactic benefit. *100mg/kg* - While higher than the standard 50mg/kg, this dose also exceeds the **AHA guidelines** for pediatric endocarditis prophylaxis. - Overdosing can lead to increased **gastrointestinal side effects** and other unwanted drug reactions.

Question 1

A 31-year-old man presents with dysuria and urethral discharge. Gram stain shows intracellular gram-negative diplococci. Local resistance patterns show 28% quinolone resistance. Which of the following most appropriately guides empiric therapy selection?

Accepted Answer

Local antimicrobial susceptibility patterns

Answer

Patient preference

Answer

Duration of therapy

Answer

Route of administration

Answer

Organism identification confirmation

Question 2

A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

Accepted Answer

Adequate initial hydration

Answer

Initial administration of allopurinol

Answer

Initial administration of glucocorticoids

Answer

Monitoring of drug levels

Answer

Obtaining a thorough history of patient allergies

Question 3

A 30-year-old man presents to his primary care physician for pain in his left ankle. The patient states that he was at karate practice when he suddenly felt severe pain in his ankle forcing him to stop. The patient has a past medical history notable for type I diabetes and is currently being treated for an episode of acute bacterial sinusitis with moxifloxacin. The patient recently had to have his insulin dose increased secondary to poorly controlled blood glucose levels. Otherwise, the patient takes ibuprofen for headaches and loratadine for seasonal allergies. Physical exam reveals a young healthy man in no acute distress. Pain is elicited over the Achilles tendon with dorsiflexion of the left foot. Pain is also elicited with plantar flexion of the left foot against resistance. Which of the following is the best next step in management?

Accepted Answer

Change antibiotics and refrain from athletic activities

Answer

Refrain from athletic activities for 1 to 2 weeks

Answer

Rehabilitation exercises and activity as tolerated

Answer

Ibuprofen and rest

Question 4

Drug of choice for nasal carriers of MRSA is:

Accepted Answer

Mupirocin

Answer

Linezolid

Answer

Vancomycin

Answer

Teicoplanin

Question 5

Praziquantel is used for the treatment of

Accepted Answer

Schistosomiasis

Answer

Rhinosporidiosis

Answer

Strongyloidiasis

Answer

Trichomoniasis

Question 6

Prophylactic dose of Oseltamivir for infants (3-11 months) is?

Accepted Answer

3 mg/kg/day

Answer

5 mg/kg/day

Answer

1 mg/kg/day

Answer

7 mg/kg/day

Question 7

Which of the following is the chemoprophylaxis of choice in a person who is on a journey to endemic malarial region?

Accepted Answer

Atovaquone-proguanil

Answer

Doxycycline

Answer

Mefloquine

Answer

Chloroquine

Question 8

Which of the following aminoglycosides is most cochleotoxic:-

Accepted Answer

Gentamycin

Answer

Streptomycin

Answer

Amikacin

Answer

Minocycline

Question 9

Empirical drug of choice for treatment of meningococcal meningitis is:-

Accepted Answer

Ceftriaxone

Answer

Cefotetan

Answer

Cefoxitin

Answer

Gentamicin

Question 10

American Heart Association standard pediatric dose of amoxicillin for antibiotic prophylaxis, in cases of endocarditis is

Accepted Answer

50mg/kg

Answer

20mg/kg

Answer

125mg/kg

Answer

100mg/kg

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?